Australian Pharmacogenomics Summit

*** THE FIRST CONFERENCE OF ITS KIND IN AUSTRALIA ***

Associate Sponsor

Attend the Australian Pharmacogenomics Summit to gain insights and leverage experience from an outstanding line-up of expert speakers including:

• Dr George Koumantakis, Roche Diagnostics
• Shelley Tang, Therapeutic Goods Administration
• Dr Andrew Somogyi, University of Adelaide
• Phil Kearney, Merck Sharp & Dohme
• Sue Forrest, Australian Genome Research Facility
• Ron Trent, Royal Prince Alfred Hospital
• Prof Robyn Ward, University of NSW
• Assoc Prof Martin Kennedy, Centre for Pharmacogenomics - University of Otago
• Prof Matt Trau, Australian Institute for Bioengineering & Nanotechnology
• Andy Bond, National E-Heath Transition Authority
• Prof Peter Visscher, Queensland Institute for Medical Research
• Prof John Rasko, Centenary Institute
• Dr Elizabeth Phillips, Murdoch University
• Dr Marienne Hibbert, BioGrid Australia
• Dr Trevor Davies, Allens Arthur Robinson
  
  

Supported by

The Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) is the professional and independent Society in Australia and New Zealand with expertise in the use and toxicity of medicines and chemicals. ASCEPT formed the Pharmacogenomics Special Interest Group in 2007 and the group is currently co-convened by Janet Coller and Andrew Somogyi. For more information please visit www.ascept.org

Endorsed by

Media Partner

The complete business and professional journal for pharmacists
Now in its 124th year, the AJP is Australia's largest circulating pharmacy publication and remains the most respected and influential publication within pharmacy, the industry and government.

Online Media Partner